rs10487937

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.97+243825C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.145 in 152,048 control chromosomes in the GnomAD database, including 4,078 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 4078 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.669

Publications

0 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.426 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.97+243825C>A
intron
N/ANP_054860.1A0A090N7T7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.97+243825C>A
intron
N/AENSP00000354778.3Q9UHC6-1
CNTNAP2
ENST00000625365.2
TSL:5
c.97+243825C>A
intron
N/AENSP00000485955.1A0A0D9SES4
CNTNAP2
ENST00000637150.1
TSL:5
n.26+243825C>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.145
AC:
21967
AN:
151930
Hom.:
4055
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.431
Gnomad AMI
AF:
0.0175
Gnomad AMR
AF:
0.0732
Gnomad ASJ
AF:
0.0754
Gnomad EAS
AF:
0.0287
Gnomad SAS
AF:
0.0431
Gnomad FIN
AF:
0.0640
Gnomad MID
AF:
0.178
Gnomad NFE
AF:
0.0210
Gnomad OTH
AF:
0.130
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.145
AC:
22025
AN:
152048
Hom.:
4078
Cov.:
32
AF XY:
0.143
AC XY:
10638
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.431
AC:
17852
AN:
41390
American (AMR)
AF:
0.0729
AC:
1114
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0754
AC:
261
AN:
3460
East Asian (EAS)
AF:
0.0288
AC:
149
AN:
5172
South Asian (SAS)
AF:
0.0417
AC:
201
AN:
4822
European-Finnish (FIN)
AF:
0.0640
AC:
678
AN:
10594
Middle Eastern (MID)
AF:
0.182
AC:
53
AN:
292
European-Non Finnish (NFE)
AF:
0.0210
AC:
1430
AN:
68016
Other (OTH)
AF:
0.128
AC:
271
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
719
1438
2157
2876
3595
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0807
Hom.:
430
Bravo
AF:
0.160
Asia WGS
AF:
0.0670
AC:
233
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.68
DANN
Benign
0.60
PhyloP100
-0.67
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10487937; hg19: chr7-146057890; API